The combination of low-intensity shockwave therapy (Li-ESWT) with phosphodiesterase 5 inhibitor (PDE-5i) medication safely improves erectile function in vasculogenic erectile dysfunction (ED) patients who had failed first-line oral therapy, a recent study has found.
Dual therapy with immune checkpoint inhibitors does not appear to prolong overall survival as compared with sunitinib alone for advanced renal cell carcinoma patients with favourable risk, according to the results of a meta-analysis.
Treatment with apalutamide plus androgen deprivation therapy (ADT) results in consistently favourable pain scores and less interference from pain in the daily lives of patients with metastatic castration-sensitive prostate cancer compared with placebo plus ADT, results of the phase III TITAN study have shown. Moreover, there was no difference for change seen in fatigue with apalutamide vs placebo.
The use of pembrolizumab significantly improved disease-free survival (DFS) in patients with clear-cell renal cell carcinoma (RCC) who have undergone nephrectomy, with or without metastasectomy, and were at high risk for recurrence, according to the phase III KEYNOTE-564 trial.
There seems to be an increasing trend in the diagnosis rate of benign prostatic hyperplasia (BPH), accompanied by a gradual rise in medical treatment and decline in surgical interventions, a new South Korea study has shown.
A recent study suggests the utilization of urine colour alone and the combination of urine colour (UC) with void number as a simple field-measure to identify underhydration in adults and children based on elevated urine osmolality (UOsm).
The obesity paradox, where obesity appears to confer a protective effect, was noted in metastatic castration-resistant prostate cancer (CRPC), with improved survival outcomes among obese patients with metastatic CRPC, according to a study from EAU21.
Chronic indwelling or intermittent bladder catheterization contributes to an increased risk of bladder cancer and related mortality, with the highest risk observed among individuals using catheters for almost 3 years as well as those with bladder calculi, as suggested in a recent study.